Retraction: Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E2 and prostaglandin E2 receptors (Carcinogenesis (2011) 32:1 (86-92) DOI: 10.1093/carcin/bgq215);Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E2 and prostaglandin E2 receptors

Carcinogenesis

Volumn 32, Issue 1, 2011, Pages 86-92

  Singh, Tripti ^a   Vaid, Mudit ^a   Katiyar, Nandan ^a   Sharma, Samriti ^a   Katiyar, Santosh K ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CAFFEIC ACID PHENETHYL ESTER; CELECOXIB; CYCLOOXYGENASE 2; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; ANTINEOPLASTIC AGENT; PROSTAGLANDIN E RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL DEATH; CELL MIGRATION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MELANOMA CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; TRANSIENT TRANSFECTION; TUMOR CELL; BIOSYNTHESIS; CELL MOTION; DRUG EFFECT; GENE EXPRESSION; GENETICS; MELANOMA; METABOLISM; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BERBERINE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION; HUMANS; MELANOMA; RECEPTORS, PROSTAGLANDIN E; TRANSFECTION;

EID: 79952198976     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgy029     Document Type: Erratum

References (30)

1. American Cancer Society. (2007) Cancer Facts and Figures. http://www.cancer.org/ (March 2010, date last accessed).
2. Maddodi,N. et al. (2008) Role of UV in cutaneous melanoma. Photochem. Photobiol., 84, 528-536.
3. Strouse,J.J. et al. (2005) Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J. Clin. Oncol., 23, 4735-4741.
4. Sharma,S.D. et al. (2010) Dietary grape seed proanthocyanidins inhibit UVB-induced cyclooxygenase-2 expression and other inflammatory mediators in UVB-exposed skin and skin tumors of SKH-1 hairless mice. Pharm. Res., 27, 1092-1102.
5. Meeran,S.M. et al. (2008) Interleukin-12-deficiency exacerbates inflammatory responses in UV-irradiated skin and skin tumors. J. Invest. Dermatol., 128, 2716-2727
6. Dohadwala,M. et al. (2002) Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J. Biol. Chem., 277, 50828-50833.
7. Riedl,K. et al. (2004) Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resist. Updat., 7, 169-184.
8. Sathyavathi,G.V. et al. (1987) Medicinal Plants of India., Vol. 2, Indian Council of Medical Research, New Delhi, India, 230-239.
9. Mantena,S.K. et al. (2006) Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol. Cancer Ther., 5, 296-308.
10. Mantena,S.K. et al. (2006) Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase-3 and PARP. Carcinogenesis, 27, 2018-2027.
11. Fukuda,K. et al. (1999) Inhibition of activation protein 1 activity by berberine in human hepatoma cells. Planta Med., 65, 381-383.
12. Lin,J.G. et al. (1999) Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells. Am. J. Chin. Med., 27, 265-275.
13. Fukuda,K. et al. (1999) Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J. Ethnopharmacol., 66, 227-233.
14. Kim,S.A. et al. (1998) Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine. Biochemistry, 37, 16316-16324.
15. Punathil,T. et al. (2008) EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase. Biochem. Biophys. Res. Commun., 375, 162-167.
16. Meeran,S.M. et al. (2009) Loss of endogenous interleukin-12 activates survival signals in UV-exposed mouse skin and skin tumors. Neoplasia, 11, 846-855.
17. Meeran,S.M. et al. (2009) Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7, 12-dimethylbenz(a)anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Carcinogenesis, 30, 520-528.
18. Sharma,S.D. et al. (2009) IL-12-deficiency suppresses 12-O-tetradecanoylphorbol-13-acetate-induced skin tumor promotion in 7, 12-dimethylbenz (a)anthracene-initiated mouse skin through inhibition of inflammation. Carcinogenesis, 30, 1970-1977.
19. Regan,J.W. (2003) EP2 and EP4 prostanoid receptor signaling. Life Sci., 74, 143-153.
20. Lucas,R. (2006) Global Burden of Disease of Solar Ultraviolet Radiation, Environmental Burden of Disease Series, No. 13. News release. World Health Organization.
21. Early Detection and Treatment of Skin Cancer. (2000) American Family Physician. http://www.aafp.org/afp/20000715/357.html (March 2010, date last accessed).
22. Balch,C.M. et al. (2000) A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer, 88, 1484-1491.
23. Mukhtar,H. et al. (1996) Photocarcinogenesis: mechanisms, models and human health implications. Photochem. Photobiol., 63, 355-447.
24. Dannenberg,A.J. et al. (2003) Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell, 4, 431-436.
25. Thun,M.J. et al. (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl Cancer Inst., 94, 252-266.
26. Tsujii,M. et al. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
27. Sheng,H. et al. (2001) Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem., 276, 18075-18081.
28. Lin,M.T. et al. (2001) Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem., 276, 48997- 49002.
29. Kim,J.I. et al. (2010) Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome. Mol. Cancer Res., 8, 569- 577.
30. Punathil,T. et al. (2009) Inhibition of non-small cell lung cancer cell migration by grape seed proanthocyanidins is mediated through the inhibition of nitric oxide, guanylate cyclase, and ERK1/2. Mol. Carcinog., 48, 232-242.